These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 8826547

  • 21. Treatment of cytomegalovirus retinitis in acquired immunodeficiency syndrome with intravitreal ganciclovir implant.
    Tayanithi P.
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S142-7. PubMed ID: 11529327
    [Abstract] [Full Text] [Related]

  • 22. Intravitreal ganciclovir in the management of non-AIDS-related human cytomegalovirus retinitis.
    Langner-Wegscheider BJ, ten Dam-van Loon N, Mura M, Faridpooya K, de Smet MD.
    Can J Ophthalmol; 2010 Apr; 45(2):157-60. PubMed ID: 20379302
    [Abstract] [Full Text] [Related]

  • 23. Retinal detachment in cytomegalovirus retinitis: intravenous versus intravitreal therapy.
    Young S, McCluskey P, Minassian DC, Joblin P, Jones C, Coroneo MT, Lightman S.
    Clin Exp Ophthalmol; 2003 Apr; 31(2):96-102. PubMed ID: 12648040
    [Abstract] [Full Text] [Related]

  • 24. Intravitreal foscarnet for cytomegalovirus retinitis in patients with AIDS.
    Ausayakhun S, Watananikorn S, Ngamtiphakorn S, Prasitsilp J.
    J Med Assoc Thai; 2005 Jan; 88(1):103-7. PubMed ID: 15960227
    [Abstract] [Full Text] [Related]

  • 25. Intraocular therapy for cytomegalovirus retinitis.
    Palestine AG.
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
    [Abstract] [Full Text] [Related]

  • 26. Oral ganciclovir for cytomegalovirus retinitis in patients with AIDS: results of two randomized studies.
    Squires KE.
    AIDS; 1996 Dec; 10 Suppl 4():S13-8. PubMed ID: 9110065
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Treatment of relapsed cytomegalovirus retinitis with the sustained-release ganciclovir implant.
    Hatton MP, Duker JS, Reichel E, Morley MG, Puliafito CA.
    Retina; 1998 Dec; 18(1):50-5. PubMed ID: 9502281
    [Abstract] [Full Text] [Related]

  • 29. Complications after implantation of intraocular devices in patients with cytomegalovirus retinitis.
    Guembel HO, Krieglsteiner S, Rosenkranz C, Hattenbach LO, Koch FH, Ohrloff C.
    Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):824-9. PubMed ID: 10502057
    [Abstract] [Full Text] [Related]

  • 30. Intravitreal sustained-release ganciclovir implantation to control cytomegalovirus retinitis in AIDS.
    Dhillon B, Kamal A, Leen C.
    Int J STD AIDS; 1998 Apr; 9(4):227-30. PubMed ID: 9598751
    [Abstract] [Full Text] [Related]

  • 31. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
    [Abstract] [Full Text] [Related]

  • 32. Ganciclovir implants: one year later.
    Cadman J.
    GMHC Treat Issues; 1997 Jul; 11(4/5):3-6. PubMed ID: 11364375
    [Abstract] [Full Text] [Related]

  • 33. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant.
    Muccioli C, Belfort R.
    Braz J Med Biol Res; 2000 Jul; 33(7):779-89. PubMed ID: 10881053
    [Abstract] [Full Text] [Related]

  • 34. Clinical outcomes in patients with cytomegalovirus retinitis treated with ganciclovir implant.
    Oktavec KC, Nolan K, Brown DM, Dunn JP, Livingston AG, Thorne JE.
    Am J Ophthalmol; 2012 Apr; 153(4):728-33, 733.e1-2. PubMed ID: 22265144
    [Abstract] [Full Text] [Related]

  • 35. Treatment of cytomegalovirus retinitis with intravitreal injection of liposome encapsulated ganciclovir in a patient with AIDS.
    Akula SK, Ma PE, Peyman GA, Rahimy MH, Hyslop NE, Janney A, Ashton P.
    Br J Ophthalmol; 1994 Sep; 78(9):677-80. PubMed ID: 7947546
    [Abstract] [Full Text] [Related]

  • 36. [Prophylaxis secondary to retinitis by CMV in patients with AIDS: the efficacy of an intermittent schedule of 3 days/week].
    Mallolas J, Gatell JM, Gómez-Sirvent JL, Buira E, Zamora L, Alecrim-Andrade J, Adán A, Morales M, Miró JM, Lonća M, Guelar A, Soriano E.
    Enferm Infecc Microbiol Clin; 1997 Feb; 15(2):61-4. PubMed ID: 9101748
    [Abstract] [Full Text] [Related]

  • 37. Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
    Taskintuna I, Rahhal FM, Arevalo JF, Munguia D, Banker AS, De Clercq E, Freeman WR.
    Ophthalmology; 1997 Jun; 104(6):1049-57. PubMed ID: 9186448
    [Abstract] [Full Text] [Related]

  • 38. Survival differences associated with treatment of cytomegalovirus retinitis in Maryland patients with AIDS, 1987-1994.
    Wutoh AK, Hidalgo J, Rhee W, Bareta J, Steidl S.
    Am J Health Syst Pharm; 1999 Jul 01; 56(13):1314-8. PubMed ID: 10683128
    [Abstract] [Full Text] [Related]

  • 39. The development of cytomegalovirus encephalitis in AIDS patients receiving ganciclovir.
    Berman SM, Kim RC.
    Am J Med; 1994 May 01; 96(5):415-9. PubMed ID: 8192172
    [Abstract] [Full Text] [Related]

  • 40. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group (ACTG).
    Am J Ophthalmol; 1997 Jul 01; 124(1):61-70. PubMed ID: 9222234
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.